P3 Health Partners [PIII] vs Pediatrix Medical [MD] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: P3 Health Partners Inc. wins in 5 metrics, Pediatrix Medical Group, Inc. wins in 12 metrics, with 1 ties. Pediatrix Medical Group, Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | P3 Health Partners Inc. | Pediatrix Medical Group, Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.06 | 11.88 | Pediatrix Medical Group, Inc. |
| Price-to-Book Ratio | -0.06 | 2.16 | Pediatrix Medical Group, Inc. |
| Debt-to-Equity Ratio | -2.05 | 73.29 | Pediatrix Medical Group, Inc. |
| PEG Ratio | 0.00 | 9.90 | Tie |
| EV/EBITDA | -1.54 | 7.92 | Pediatrix Medical Group, Inc. |
| Profit Margin (TTM) | -10.14% | 8.64% | Pediatrix Medical Group, Inc. |
| Operating Margin (TTM) | -39.99% | 11.07% | Pediatrix Medical Group, Inc. |
| EBITDA Margin (TTM) | N/A | 11.07% | N/A |
| Return on Equity | -6,952.57% | 20.28% | Pediatrix Medical Group, Inc. |
| Return on Assets (TTM) | -23.46% | 6.57% | Pediatrix Medical Group, Inc. |
| Free Cash Flow (TTM) | $-91.24M | $252.63M | Pediatrix Medical Group, Inc. |
| 1-Year Return | 83.08% | 73.57% | P3 Health Partners Inc. |
| Price-to-Sales Ratio (TTM) | 0.01 | 1.00 | P3 Health Partners Inc. |
| Enterprise Value | $286.21M | $2.00B | Pediatrix Medical Group, Inc. |
| EV/Revenue Ratio | 0.20 | 1.05 | P3 Health Partners Inc. |
| Gross Profit Margin (TTM) | N/A | 25.51% | N/A |
| Revenue per Share (TTM) | $446 | $23 | P3 Health Partners Inc. |
| Earnings per Share (Diluted) | $-45.26 | $1.94 | Pediatrix Medical Group, Inc. |
| Beta (Stock Volatility) | 0.56 | 0.72 | P3 Health Partners Inc. |
| Short % of Float | 24.77% | 6.00% | Pediatrix Medical Group, Inc. |
P3 Health Partners Inc. vs Pediatrix Medical Group, Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| P3 Health Partners Inc. | -4.42% | -4.57% | 3.54% | 284.54% | 136.16% | 234.00% |
| Pediatrix Medical Group, Inc. | 0.29% | 8.46% | 8.36% | 25.04% | 7.40% | 14.47% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| P3 Health Partners Inc. | 83.08% | -93.73% | -97.55% | -97.50% | -97.50% | -97.50% |
| Pediatrix Medical Group, Inc. | 73.57% | 75.20% | -20.69% | -64.71% | -31.34% | 9.12% |
Performance & Financial Health Analysis: P3 Health Partners Inc. vs Pediatrix Medical Group, Inc.
| Metric | PIII | MD |
|---|---|---|
| Market Information | ||
| Market Cap | $551.61M | $1.91B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 22,238 | 510,889 |
| 90 Day Avg. Volume | 43,416 | 755,756 |
| Last Close | $11.69 | $24.37 |
| 52 Week Range | $1.52 - $16.89 | $11.84 - $24.99 |
| % from 52W High | -30.79% | -2.48% |
| All-Time High | $16.89 (May 28, 2026) | $86.09 (Aug 17, 2015) |
| % from All-Time High | -30.79% | -71.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | -0.02% |
| Quarterly Earnings Growth | 0.04% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | -0.10% | 0.09% |
| Operating Margin (TTM) | -0.40% | 0.11% |
| Return on Equity (TTM) | -69.53% | 0.20% |
| Debt to Equity (MRQ) | -2.05 | 73.29 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-47.24 | $10.68 |
| Cash per Share (MRQ) | $7.59 | $6.16 |
| Operating Cash Flow (TTM) | $-91,238,000 | $271.09M |
| Levered Free Cash Flow (TTM) | $16.28M | $190.33M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: P3 Health Partners Inc. vs Pediatrix Medical Group, Inc.
| Metric | PIII (Apr 24, 2026) | MD (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.06 | 11.88 |
| Forward P/E | -12.93 | 9.90 |
| PEG Ratio | 0.00 | 9.90 |
| Price to Sales (TTM) | 0.01 | 1.00 |
| Price to Book (MRQ) | -0.06 | 2.16 |
| Market Capitalization | ||
| Market Capitalization | $551.61M | $1.91B |
| Enterprise Value | $286.21M | $2.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.20 | 1.05 |
| Enterprise to EBITDA | -1.54 | 7.92 |
| Risk & Other Metrics | ||
| Beta | 0.56 | 0.72 |
| Book Value per Share (MRQ) | $-47.24 | $10.68 |
Financial Statements Comparison: P3 Health Partners Inc. vs Pediatrix Medical Group, Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PIII (2025) | MD (2025) |
|---|---|---|
| Revenue/Sales | 1.46B | 1.91B |
| Cost of Goods Sold | N/A | 1.42B |
| COGS % of Revenue | 0.0% | 74.2% |
| Gross Profit | N/A | 493.70M |
| Gross Margin | 0.0% | 25.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -270.30M | 231.09M |
| Operating Margin | -18.5% | 12.1% |
| EBITDA | -189.55M | 256.55M |
| EBITDA Margin | -13.0% | 13.4% |
| Pre-Tax Income | -321.06M | 216.43M |
| Pre-Tax Income % of Revenue | -22.0% | 11.3% |
| Income Tax | 2.03M | 51.04M |
| Income Tax % of Revenue | 0.1% | 2.7% |
| Net Income (Profit) | -323.09M | 165.39M |
| Profit Margin | -22.1% | 8.6% |
Balance Sheet & Liquidity Metrics
| Metric | PIII (2025) | MD (2025) |
|---|---|---|
| Cash & Equivalents | 25.01M | 375.24M |
| Total Current Assets | 133.08M | 763.51M |
| Total Current Assets % of Revenue | 9.1% | 39.9% |
| Total Current Liabilities | 545.26M | 458.91M |
| Total Current Liabilities % of Revenue | 37.4% | 24.0% |
| Long-Term Debt | 239.85M | 596.22M |
| Long-Term Debt % of Revenue | 16.4% | 31.2% |
| Total Shareholders Equity | -140.24M | 865.85M |
| Retained Earnings | -651.14M | -83.15M |
| Retained Earnings % of Revenue | -44.6% | -4.3% |
| Property, Plant & Equipment | 1.02M | 195.53M |
Cash Flow Statement Comparison
| Metric | PIII (2025) | MD (2025) |
|---|---|---|
| Operating Cash Flow | -152.60M | 270.23M |
| Operating Cash Flow % of Revenue | -10.5% | 14.1% |
| Capital Expenditures | 79,000 | -18.46M |
| Free Cash Flow | -91.24M | 252.63M |
| FCF Margin | -6.3% | 13.2% |
| Debt Repayment | -1.14M | -20.75M |
| Common Stock Repurchase | N/A | -86.68M |
Short Interest & Institutional Ownership Analysis
| Metric | PIII | MD |
|---|---|---|
| Shares Short | 94,972 | 3.53M |
| Short Ratio | 0.79 | 3.77 |
| Short % of Float | 24.77% | 6.00% |
| Shares Outstanding | 3.29M | 82.98M |
| Float Shares | 1.41M | 79.95M |
| % Held by Insiders | 51.12% | 2.31% |
| % Held by Institutions | 8.86% | 106.63% |
| % Held by Public | 40.02% | -8.94% |
Dividend Analysis & Yield Comparison: P3 Health Partners Inc. vs Pediatrix Medical Group, Inc.
| Metric | PIII | MD |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |